{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:32:17Z","timestamp":1781105537085,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Health Committee Key Laboratory of Hypertension Clinical Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12020-021-02920-w","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T07:02:43Z","timestamp":1636959763000},"page":"889-898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Plasma aldosterone concentration is associated with white matter lesions in patients with primary aldosteronism"],"prefix":"10.1007","volume":"75","author":[{"given":"Yujuan","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1505-8566","authenticated-orcid":false,"given":"Nanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulalibieke","family":"Heizhati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"issue":"14","key":"2920_CR1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"S. Monticone, J. Burrello, D. Tizzani, C. Bertello, A. Viola, F. Buffolo, L. Gabetti, G. Mengozzi, Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J. Am. Coll. Cardiol. 69(14), 1811\u20131820 (2017). https:\/\/doi.org\/10.1016\/j.jacc.2017.01.052","journal-title":"J. Am. Coll. Cardiol."},{"key":"2920_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/bs.vh.2018.10.006","volume":"109","author":"JW Funder","year":"2019","unstructured":"J.W. Funder, Primary aldosteronism: present and future. Vitam. Horm. 109, 285\u2013302 (2019). https:\/\/doi.org\/10.1016\/bs.vh.2018.10.006","journal-title":"Vitam. Horm."},{"issue":"5","key":"2920_CR3","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata, M. Stowasser, W.F. Young Jr., The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J. Clin. Endocrinol Metab. 101(5), 1889\u20131916 (2016). https:\/\/doi.org\/10.1210\/jc.2015-4061","journal-title":"J. Clin. Endocrinol Metab."},{"issue":"9","key":"2920_CR4","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/HJH.0000000000002441","volume":"38","author":"M Parasiliti-Caprino","year":"2020","unstructured":"M. Parasiliti-Caprino, C. Lopez, N. Prencipe, B. Lucatello, F. Settanni, G. Giraudo, D. Rossato, Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension. J. Hypertens. 38(9), 1841\u20131848 (2020). https:\/\/doi.org\/10.1097\/HJH.0000000000002441","journal-title":"J. Hypertens."},{"issue":"3","key":"2920_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1161\/HYPERTENSIONAHA.117.10405","volume":"71","author":"M Reincke","year":"2018","unstructured":"M. Reincke, Primary aldosteronism and cardiovascular events: it is time to take guideline recommendations seriously. Hypertension 71(3), 413\u2013414 (2018). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10405","journal-title":"Hypertension"},{"key":"2920_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/srep32103","volume":"6","author":"VC Wu","year":"2016","unstructured":"V.C. Wu, S.M. Wang, C.H. Chang, Y.H. Hu, L.Y. Lin, Y.H. Lin, S.C. Chueh, L. Chen, K.D. Wu, Long term outcome of aldosteronism after target treatments. Sci. Rep. 6, 32103 (2016). https:\/\/doi.org\/10.1038\/srep32103","journal-title":"Sci. Rep."},{"key":"2920_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"S. Monticone, F. D\u2019Ascenzo, C. Moretti, T.A. Williams, F. Veglio, F. Gaita, P. Mulatero, Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 6, 41\u201350 (2018). https:\/\/doi.org\/10.1016\/S2213-8587(17)30319-4","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2920_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2018","unstructured":"G.L. Hundemer, G.C. Curhan, N. Yozamp, M. Wang, A. Vaidya, Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 6, 51\u201359 (2018). https:\/\/doi.org\/10.1016\/S2213-8587(17)30367-4","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"2920_CR9","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","volume":"46","author":"PJ Fuller","year":"2005","unstructured":"P.J. Fuller, M.J. Young, Mechanisms of mineralocorticoid action. Hypertension. 46(6), 1227\u20131235 (2005). https:\/\/doi.org\/10.1161\/01.HYP.0000193502.77417.17","journal-title":"Hypertension."},{"issue":"4","key":"2920_CR10","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1210\/en.2011-1176","volume":"153","author":"CA Northcott","year":"2012","unstructured":"C.A. Northcott, G.D. Fink, H. Garver, J.R. Haywood, E.L. Laimon-Thomson, J.L. McClain, P.W. Pires, W.E. Rainey, C.S. Rigsby, A.M. Dorrance, The development of hypertension and hyperaldosteronism in a rodent model of life-long obesity. Endocrinology. 153(4), 1764\u20131773 (2012). https:\/\/doi.org\/10.1210\/en.2011-1176","journal-title":"Endocrinology."},{"issue":"5","key":"2920_CR11","doi-asserted-by":"publisher","first-page":"e12460","DOI":"10.1111\/micc.12460","volume":"25","author":"PW Pires","year":"2018","unstructured":"P.W. Pires, J.L. Mclain, S.F. Hayoz, A.M. Dorrance, Mineralocorticoid receptor antagonism prevents obesity-induced cerebral artery remodeling and reduces white matter injury in rats. Microcirculation. 25(5), e12460 (2018). https:\/\/doi.org\/10.1111\/micc.12460","journal-title":"Microcirculation."},{"key":"2920_CR12","doi-asserted-by":"publisher","unstructured":"Q.N. Dinh, M.J. Young, M.A. Evans, G.R. Drummond, C.G. Sobey, S. Chrissobolis, Aldosterone-induced oxidative stress and inflammation in the brain are mediated by the endothelial cell mineralocorticoid receptor. Brain Res. 1637, 146\u2013153 (2016). https:\/\/doi.org\/10.1016\/j.brainres.2016.02.034","DOI":"10.1016\/j.brainres.2016.02.034"},{"issue":"8","key":"2920_CR13","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"J.M. Wardlaw, E.E. Smith, G.J. Biessels, C. Cordonnier, F. Fazekas, R. Frayne, R.I. Lindley, J.T. O\u2019Brien et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 12(8), 822\u2013838 (2013). https:\/\/doi.org\/10.1016\/S1474-4422(13)70124-8","journal-title":"Lancet Neurol."},{"key":"2920_CR14","doi-asserted-by":"publisher","unstructured":"M.E. Cahgiuri, P. Peotta, A. Augimeri, F. Rocca, A. Quattrone, A. Cherubini, Automatic detection of white matter hyperintensities in healthy aging and pathology using magnetic resollauce knagmg: a review. Neuromformatics 13(31), 261\u2013276 (2015). https:\/\/doi.org\/10.1007\/s1202l-015.9260-v","DOI":"10.1007\/s1202l-015.9260-v"},{"issue":"10","key":"2920_CR15","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1161\/STROKEAHA.117.018101","volume":"48","author":"AH Hainsworth","year":"2017","unstructured":"A.H. Hainsworth, J. Miner T\u2019Andoh, G. Forster, I. Bhide, T.R. Barrick, K. Elderfield, J. Jeevahan, H.S. Markus, L.R. Bridges, Neuropathology of white matter lesions, blood-brain barrier dysfunction, and dementia. Stroke 48(10), 2799\u20132804 (2017). https:\/\/doi.org\/10.1161\/STROKEAHA.117.018101","journal-title":"Stroke"},{"key":"2920_CR16","doi-asserted-by":"crossref","unstructured":"Y.P. Coutu, A. Goldblatt, I.-I.D. Rosas, D.H. Rosas, Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI), White matter changes are associated with ventricular expansion in aging, mild cognitive impairment, and Alzheimer\u2019s disease. J. AIzheimers Dis. 49(2), 329\u2013342 (2016). 10.3233HAD-150306.","DOI":"10.3233\/JAD-150306"},{"key":"2920_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jpsychires.2014.05.005","volume":"56","author":"L Wang","year":"2014","unstructured":"L. Wang, C.O. Leonards, P. Sterzer, M. Ebinger, White matter lesions and depression: a systematic review and meta-analysis. J. Psychiatr. Res. 56, 56\u201364 (2014). https:\/\/doi.org\/10.1016\/j.jpsychires.2014.05.005","journal-title":"J. Psychiatr. Res."},{"key":"2920_CR18","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1161\/01.STR.0000132193.35955.69","volume":"35","author":"LH Kuller","year":"2004","unstructured":"L.H. Kuller, W.T. Longstreth, A.M. Arnold, C. Bernick, R.N. Bryan, N.J. Beauchamp, White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 35, 1821\u20131825 (2004). https:\/\/doi.org\/10.1161\/01.STR.0000132193.35955.69","journal-title":"Stroke"},{"issue":"7","key":"2920_CR19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","volume":"9","author":"L Pantoni","year":"2010","unstructured":"L. Pantoni, Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 9(7), 689\u2013701 (2010). https:\/\/doi.org\/10.1016\/S1474-4422(10)70104-6","journal-title":"Lancet Neurol."},{"issue":"11","key":"2920_CR20","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1093\/gerona\/glt072","volume":"68","author":"L Wolfson","year":"2013","unstructured":"L. Wolfson, D.B. Wakefield, N. Moscufo, R.F. Kaplan, C.B. Hall, J.A. Schmidt, C.R. Guttmann, W.B. White, Rapid buildup of brain white matter hyperintensities over 4 years linked toambulatory blood pressure, mobility, cognition, and depression in old persons. J. Gerontol. A Biol. Sci. Med. Sci. 68(11), 1387\u20131394 (2013). https:\/\/doi.org\/10.1093\/gerona\/glt072","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"2920_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/ageing\/afx102","volume":"47","author":"CJ McNeil","year":"2018","unstructured":"C.J. McNeil, P.K. Myint, A.L. Sandu, J.F. Potter, R. Staff, L.J. Whalley, A.D. Murray, Increased diastolic blood pressure is associated with MRI biomarkers of dementia-related brain pathology in normative ageing. Age Ageing 47, 95\u2013100 (2018). https:\/\/doi.org\/10.1093\/ageing\/afx102","journal-title":"Age Ageing"},{"key":"2920_CR22","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1161\/HYPERTENSIONAHA.113.02735","volume":"63","author":"BS Aribisala","year":"2014","unstructured":"B.S. Aribisala, Z. Morris, E. Eadie, A. Thomas, A. Gow, M.C. V ald\u00e9s Hern\u00e1ndez, N.A. Royle, M.E. Bastin, Blood pressure, internal carotid artery flow parameters, and age-related white matter hyperintensities. Hypertension 63, 1011\u20131018 (2014). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.02735","journal-title":"Hypertension"},{"key":"2920_CR23","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1093\/ajh\/hpy104","volume":"31","author":"M Shokouhi","year":"2018","unstructured":"M. Shokouhi, D. Qiu, A. Samman Tahhan, A.A. Quyyumi, I. Hajjar, Differential associations of diastolic and systolic pressures with cerebral measures in older individuals with mild cognitive impairment. Am. J. Hypertens. 31, 1268\u20131277 (2018). https:\/\/doi.org\/10.1093\/ajh\/hpy104","journal-title":"Am. J. Hypertens."},{"key":"2920_CR24","doi-asserted-by":"publisher","unstructured":"J.F. Meschia, C.D. Bushnell, B. Boden-Albala, L.Y. Braun, D.M. Bravata, S. Chaturvedi, J.F. Meschia, C. Bushnell, B. Boden-Albala, L.T. Braun, D.M. Bravata, S. Chaturvedi, M.A. Creager, R.H. Eckel, M.S. Elkind, M. Fornage, L.B. Goldstein, S.M. Greenberg, S.E. Horvath, C. Iadecola, E.C. Jauch, W.S. Moore, J.A. Wilson; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Functional Genomics and Translational Biology; Council on Hypertension, Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 45, 3754\u20133832 (2014). https:\/\/doi.org\/10.1161\/STR.0000000000000046","DOI":"10.1161\/STR.0000000000000046"},{"key":"2920_CR25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1001\/jama.2019.10575","volume":"322","author":"KA Walker","year":"2019","unstructured":"K.A. Walker, A.R. Sharrett, A. Wu, A.L.C. Schneider, M. Albert, P.L. Lutsey, K. Bandeen-Roche, J. Coresh, A.L. Gross, B.G. Windham, D.S. Knopman, M.C. Power, A.M. Rawlings, T.H. Mosley, R.F. Gottesman, Association of midlife to late-life blood pressure patterns with incident dementia. JAMA 322, 535\u2013545 (2019). https:\/\/doi.org\/10.1001\/jama.2019.10575","journal-title":"JAMA"},{"issue":"5","key":"2920_CR26","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata, M. Stowasser, W.F. Young Jr., The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(5), 1889\u20131916 (2016). https:\/\/doi.org\/10.1210\/jc.2015-4061","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"2920_CR27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41440-020-00589-8","volume":"44","author":"X Wang","year":"2021","unstructured":"X. Wang, Q. Luo, M. Wang, J. Hu, D. Zhang, W. Zhang, G. Wang, N. Li, Long-term impact of spironolactone compliance on microalbuminuria in patients with primary aldosteronism. Hypertens Res. 44(4), 426\u2013434 (2021). https:\/\/doi.org\/10.1038\/s41440-020-00589-8","journal-title":"Hypertens Res."},{"issue":"9","key":"2920_CR28","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41371-019-0291-y","volume":"34","author":"Q Luo","year":"2020","unstructured":"Q. Luo, N. Li, M. Wang, X. Yao, M. Heizhati, D. Zhang, K. Zhou, G. Wang, J. Hu, B. Zhu, Mild primary aldosteronism (PA) followed by overt PA are possibly the most common forms of low renin hypertension: a single-center retrospective study. J. Hum. Hypertens. 34(9), 633\u2013640 (2020). https:\/\/doi.org\/10.1038\/s41371-019-0291-y","journal-title":"J. Hum. Hypertens."},{"issue":"1","key":"2920_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/jhh.2015.21","volume":"30","author":"Q Luo","year":"2016","unstructured":"Q. Luo, N.F. Li, X.G. Yao, D.L. Zhang, S.F. Abulikemu, G.J. Chang, K.M. Zhou, G.L. Wang, M.H. Wang, W.J. Ouyang, Q.Y. Cheng, Y. Jia, Potential effects of age on screening for primary aldosteronism. J. Hum. Hypertens. 30(1), 53\u201361 (2016). https:\/\/doi.org\/10.1038\/jhh.2015.21","journal-title":"J. Hum. Hypertens."},{"key":"2920_CR30","doi-asserted-by":"publisher","unstructured":"F. Beygui, G. Montalescot, E. Vicaut, S. Rouanet, E. Van Belle, C. Baulac, A. Degrandsart, J. Dallongeville; OPERA Investigator, Aldosterone and long-term outcome after myocardial infarction: a substudy of the French nationwide observatoire sur la prise en charge hospitali\u00e8re, l\u2019Evolution \u00e0 un an et les caRact\u00e9ristiques de patients pr\u00e9sentant un infArctus du myocarde avec ou sans onde Q (OPERA) study. Am. Heart J. 157, 680\u2013687 (2009). https:\/\/doi.org\/10.1016\/j.ahj.2008.12.013","DOI":"10.1016\/j.ahj.2008.12.013"},{"key":"2920_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/eurheartj\/ehr176","volume":"33","author":"F Ivanes","year":"2012","unstructured":"F. Ivanes, S. Susen, F. Mouquet, P. Pigny, F. Cuilleret, K. Sauti\u00e8re, J.P. Collet, F. Beygui, B. Hennache, P.V. Ennezat et al. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. Eur. Heart J. 33, 191\u2013202 (2012). https:\/\/doi.org\/10.1093\/eurheartj\/ehr176","journal-title":"Eur. Heart J."},{"key":"2920_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"S. Monticone, F. D\u2019Ascenzo, C. Moretti, T.A. Williams, F. Veglio, F. Gaita, P. Mulatero, Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 6, 41\u201350 (2018). https:\/\/doi.org\/10.1016\/S2213-8587(17)30319-4","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2920_CR33","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1161\/01.CIR.0000127949.05756.9D","volume":"109","author":"S Keidar","year":"2004","unstructured":"S. Keidar, M. Kaplan, E. Pavlotzky, R. Coleman, T. Hayek, S. Hamoud, M. Aviram, Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development. Circulation. 109, 2213\u20132220 (2004). https:\/\/doi.org\/10.1161\/01.CIR.0000127949.05756.9D","journal-title":"Circulation."},{"key":"2920_CR34","doi-asserted-by":"publisher","first-page":"e000018","DOI":"10.1161\/JAHA.112.000018","volume":"2","author":"AP McGraw","year":"2013","unstructured":"A.P. McGraw, J. Bagley, W.S. Chen, C. Galayda, H. Nickerson, A. Armani, M. Caprio, P. Carmeliet, I.Z. Jaffe, Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism. J. Am. Heart Assoc. 2, e000018 (2013). https:\/\/doi.org\/10.1161\/JAHA.112.000018","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"2920_CR35","doi-asserted-by":"publisher","first-page":"H127","DOI":"10.1152\/ajpheart.00168.2015","volume":"309","author":"PW Pires","year":"2015","unstructured":"P.W. Pires, W.F. Jackson, A.M. Dorrance, Regulation of myogenic tone and structure of parenchymal arterioles by hypertension and the mineralocorticoid receptor. Am. J. Physiol. Heart Circ. Physiol. 309(1), H127\u2013H136 (2015). https:\/\/doi.org\/10.1152\/ajpheart.00168.2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"2920_CR36","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1161\/01.HYP.0000196945.73586.0d","volume":"47","author":"AM Dorrance","year":"2006","unstructured":"A.M. Dorrance, N.C. Rupp, E.F. Nogueira, Mineralocorticoid receptor activation causes cerebral vessel remodeling and exacerbates the damage caused by cerebral ischemia. Hypertension. 47(3), 590\u2013595 (2006). https:\/\/doi.org\/10.1161\/01.HYP.0000196945.73586.0d","journal-title":"Hypertension."},{"issue":"5","key":"2920_CR37","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1212\/wnl.56.5.673","volume":"56","author":"P Verpillat","year":"2001","unstructured":"P. Verpillat, A. Alp\u00e9rovitch, F. Cambien, V. Besan\u00e7on, H. Desal, C. Tzourio, Aldosterone synthase (CYP11B2) gene polymorphism and cerebral white matter hyperintensities. Neurology 56(5), 673\u2013675 (2001). https:\/\/doi.org\/10.1212\/wnl.56.5.673","journal-title":"Neurology"},{"issue":"4","key":"2920_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0022-4731(90)90215-e","volume":"36","author":"PJ Fuller","year":"1990","unstructured":"P.J. Fuller, K. Verity, Mineralocorticoid receptor gene expression in the gastrointestinal tract: distribution and ontogeny. J. Steroid. Biochem. 36(4), 263\u2013267 (1990). https:\/\/doi.org\/10.1016\/0022-4731(90)90215-e","journal-title":"J. Steroid. Biochem."},{"key":"2920_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/bs.vh.2018.09.004","volume":"109","author":"PJ Fuller","year":"2019","unstructured":"P.J. Fuller, J. Yang, M.J. Young, Mechanisms of mineralocorticoid receptor signaling. Vitam. Horm. 109, 37\u201368 (2019). https:\/\/doi.org\/10.1016\/bs.vh.2018.09.004","journal-title":"Vitam. Horm."},{"issue":"7","key":"2920_CR40","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/STROKEAHA.121.034984","volume":"52","author":"T De Silva","year":"2021","unstructured":"T.M. De Silva, M.L. Modrick, J.L. Grobe, F.M. Faraci, Activation of the central renin-angiotensin system causes local cerebrovascular dysfunction. Stroke. 52(7), 2404\u20132413 (2021). https:\/\/doi.org\/10.1161\/STROKEAHA.121.034984","journal-title":"Stroke."},{"issue":"6","key":"2920_CR41","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/HYPERTENSIONAHA.117.09598","volume":"70","author":"JM Diaz-Otero","year":"2017","unstructured":"J.M. Diaz-Otero, C. Fisher, K. Downs, M.E. Moss, I.Z. Jaffe, W.F. Jackson, A.M. Dorrance, Endothelial mineralocorticoid receptor mediates parenchymal arteriole and posterior cerebral artery remodeling during angiotensin II-induced hypertension. Hypertension. 70(6), 1113\u20131121 (2017). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.09598","journal-title":"Hypertension."},{"issue":"5","key":"2920_CR42","doi-asserted-by":"publisher","first-page":"e12460","DOI":"10.1111\/micc.12460","volume":"25","author":"PW Pires","year":"2018","unstructured":"P.W. Pires, J.L. McClain, S.F. Hayoz, A.M. Dorrance, Mineralocorticoid receptor antagonism prevents obesity-induced cerebral artery remodeling and reduces white matter injury in rats. Microcirculation 25(5), e12460 (2018). https:\/\/doi.org\/10.1111\/micc.12460","journal-title":"Microcirculation"},{"issue":"11","key":"2920_CR43","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1161\/STROKEAHA.117.018148","volume":"48","author":"LS Johnson","year":"2017","unstructured":"L.S. Johnson, N. Mattsson, A. Sajadieh, P. Wollmer, M. S\u00f6derholm, Serum potassium is positively associated with stroke and mortality in the large, population-based malm\u00f6 preventive project cohort. Stroke 48(11), 2973\u20132978 (2017). https:\/\/doi.org\/10.1161\/STROKEAHA.117.018148","journal-title":"Stroke"},{"issue":"7","key":"2920_CR44","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.03.041","volume":"28","author":"F Matano","year":"2019","unstructured":"F. Matano, Y. Fujiki, T. Mizunari, K. Koketsu, T. Tamaki, Y. Murai, H. Yokota, A. Morita, Serum glucose and potassium ratio as risk factors for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J. Stroke Cerebrovasc. Dis. 28(7), 1951\u20131957 (2019). https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2019.03.041","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"1036","key":"2920_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/postgradmedj-2011-130307","volume":"88","author":"BE Grueter","year":"2012","unstructured":"B.E. Grueter, U.G. Schulz, Age-related cerebral white matter disease (leukoaraiosis): a review. Postgrad. Med. J. 88(1036), 79\u201387 (2012). https:\/\/doi.org\/10.1136\/postgradmedj-2011-130307","journal-title":"Postgrad. Med. J."},{"key":"2920_CR46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neurobiolaging.2018.10.005","volume":"74","author":"D Fuhrmann","year":"2019","unstructured":"D. Fuhrmann, D. Nesbitt, M. Shafto, J.B. Rowe, D. Price, A. Gadie, C. CAN, R.A. Kievit, Strong and specifific associations between cardiovascular risk factors and white matter micro- and macrostructure in healthy aging. Neurobiol. Aging 74, 46\u201355 (2019). https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.10.005","journal-title":"Neurobiol. Aging"},{"issue":"12","key":"2920_CR47","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/ene.12511","volume":"21","author":"C Annweiler","year":"2014","unstructured":"C. Annweiler, T. Annweiler, R. Bartha, F.R. Herrmann, R. Camicioli, O. Beauchet, Vitamin D and white matter abnormalities in older adults: a cross-sectional neuroimaging study. Eur. J. Neurol. 21(12), 1436\u2013e95 (2014). https:\/\/doi.org\/10.1111\/ene.12511","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"2920_CR48","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/CIRCULATIONAHA.110.961052","volume":"123","author":"O Godin","year":"2011","unstructured":"O. Godin, C. Tzourio, P. Maillard, B. Mazoyer, C. Dufouil, Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation 123(3), 266\u2013273 (2011). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.961052","journal-title":"Circulation"},{"issue":"2","key":"2920_CR49","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/STROKEAHA.119.025139","volume":"51","author":"MR Caunca","year":"2020","unstructured":"M.R. Caunca, M. Simonetto, Y.K. Cheung, N. Alperin, S.H. Lee, M.S.V. Elkind, R.L. Sacco, T. Rundek, Diastolic blood pressure is associated with regional white matter lesion load: the Northern Manhattan Study. Stroke. 51(2), 372\u2013378 (2020). https:\/\/doi.org\/10.1161\/STROKEAHA.119.025139","journal-title":"Stroke."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02920-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02920-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02920-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T09:12:31Z","timestamp":1646125951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02920-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2920"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02920-w","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741176933.793590353","asserted-by":"object"}]},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"assertion":[{"value":"30 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Yes","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The study was approved by the Ethics Committee of People\u2019s Hospital of Xinjiang Uygur Autonomous Region. Due to retrospective nature of the study and use of anonymized data, we waived need for informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}